Cullinan Therapeutics, Inc.: Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

Cullinan Therapeutics, Inc. Cullinan Therapeutics shares additional preclinical B cell depletion data for CLN-978, supporting clinical development across multiple autoimmune diseases, at A…